Validity, Significance, Strengths, Limitations, and Evidentiary Value of Real-World Clinical Data for Combination Therapy in Alzheimers Disease: Comparison of Efficacy and Effectiveness Studies-Reference-Cited by-同舟云学术

Validity, Significance, Strengths, Limitations, and Evidentiary Value of Real-World Clinical Data for Combination Therapy in Alzheimers Disease: Comparison of Efficacy and Effectiveness Studies

Published:2012 Issue:1-4 Volume:10 Page:170-174
ISSN:1660-2862
Container-title:Neurodegenerative Diseases
language:en
Short-container-title:Neurodegenerative Dis

Author:

Atri Alireza,Rountree Susan D.,Lopez Oscar L.,Doody Rachelle S.

Publisher

S. Karger AG

Subject

Neurology (clinical),Neurology

Reference32 articles.

1. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity

2. External validity of randomised controlled trials: “To whom do the results of this trial apply?”

3. Explanatory and pragmatic attitudes in therapeutical trials

4. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial Commentary: Another piece of the Alzheimer's jigsaw

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generating real‐world evidence in Alzheimer's disease: Considerations for establishing a core dataset;Alzheimer's & Dementia;2024-05-06

2. Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease;Alzheimer's Research & Therapy;2022-04-19

3. Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis;Journal of Internal Medicine;2021-03-31

4. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia;Cochrane Database of Systematic Reviews;2021-02-03

5. Placebo—To be or not to be? Are there really alternatives to placebo-controlled trials?;European Neuropsychopharmacology;2020-03